Alleghany Corporation’s Thermo Fisher Scientific TMO Stock Holding History

Alleghany Corporation’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	$119M	Hold	234,060	–	–	5.36%	5
2022 Q2	$127M	Hold	234,060	–	–	4.81%	8
2022 Q1	$138M	Hold	234,060	–	–	4.36%	7
2021 Q4	$156M	Hold	234,060	–	–	4.54%	6
2021 Q3	$134M	Hold	234,060	–	–	4.12%	7
2021 Q2	$118M	Hold	234,060	–	–	3.52%	13
2021 Q1	$107M	Hold	234,060	–	–	3.42%	16
2020 Q4	$109M	Buy	234,060 +10,534	+5%	+$4.94M	4.34%	9
2020 Q3	$98.7M	Hold	223,526	–	–	5.02%	8
2020 Q2	$81M	Sell	223,526 -158,389	-41%	-$53.1M	6.49%	6
2020 Q1	$108M	Sell	381,915 -39,542	-9%	-$12.5M	7.29%	5
2019 Q4	$137M	Hold	421,457	–	–	6.34%	6
2019 Q3	$123M	Hold	421,457	–	–	7.02%	6
2019 Q2	$124M	Sell	421,457 -25,543	-6%	-$7.04M	6.43%	6
2019 Q1	$122M	Buy	447,000 +109,000	+32%	+$27.1M	5.8%	8
2018 Q4	$75.6M	Buy	338,000 +38,000	+13%	+$8.92M	2.69%	14
2018 Q3	$73.2M	Buy	300,000 +60,000	+25%	+$13.8M	1.76%	19
2018 Q2	$49.7M	Hold	240,000	–	–	1.28%	23
2018 Q1	$49.6M	Buy	+240,000	New	+$50.4M	1.32%	22

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Alleghany Corporation's TMO Position: Q3 2022 in Review

Alleghany Corporation held its Thermo Fisher Scientific (TMO) position steady in Q3 2022 at 234,060 shares worth $119M. The position accounts for 5.36% of the portfolio, ranked #5.

Alleghany Corporation first reported a position in TMO in Q1 2018 and has held it in 19 quarters since. The position peaked at $156M in Q4 2021. 2,268 funds tracked by Wall St. Rank hold TMO as of Q3 2022.

Alleghany Corporation held 234,060 shares of Thermo Fisher Scientific worth $119M as of Q3 2022.
Alleghany Corporation left its Thermo Fisher Scientific share count unchanged in Q3 2022.
Thermo Fisher Scientific made up 5.36% of Alleghany Corporation's portfolio in Q3 2022, its #5 holding.
Alleghany Corporation first reported a position in Thermo Fisher Scientific in Q1 2018 and has held it in 19 quarters since.
Alleghany Corporation's Thermo Fisher Scientific position peaked at $156M in Q4 2021.
2,268 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2022.

Based on Alleghany Corporation's 13F filing for Q3 2022, filed 1 Nov 2022.